Latest Breaking News On - Company on twitter at milestonepharma - Page 1 : comparemela.com

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesDavid pittsMilestone pharmaceuticals incCompany on twitter at milestonepharmaMilestone compensation committeeMilestone pharmaceuticalsPrnewswire milestone pharmaceuticals incCompensation committee

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesDavid pittsMilestone pharmaceuticals incCompany on twitter at milestonepharmaMilestone compensation committeeMilestone pharmaceuticalsPrnewswire milestone pharmaceuticals incCompensation committee

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesSan franciscoJames ipDavid pittsJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionCompany on twitter at milestonepharmaHeart rhythm societyDivision of cardiologyPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsHeart rhythmNasal spray is effectiveRepeated spontaneous episodes

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJames ipJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionCompany on twitter at milestonepharmaHeart rhythm societyDivision of cardiologyPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsHeart rhythmNasal spray is effectiveRepeated spontaneous episodesResults from

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesSan franciscoJames ipDavid pittsJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionCompany on twitter at milestonepharmaHeart rhythm societyDivision of cardiologyPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsHeart rhythmNasal spray is effectiveRepeated spontaneous episodes